ZVRA
ZVRA
NASDAQ · Pharmaceuticals

Zevra Therapeutics Inc

$12.88
+0.23 (+1.82%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target -58.5% upside
Low Target $3.67
Average Target $5.34
High Target $6.76
Current Price $12.88
Current
$12.88
Target
$5.34
$3.67 $5.34 avg $6.76
Scenario Analysis
Bear Case
$3.67
-71.5%
Low target
Base Case
$5.34
-58.5%
Avg target
Bull Case
$6.76
+-47.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$14.27
-9.7% from high
52-Week Low
$7.16
+79.9% from low
Target vs 52W High
$5.34
-62.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%